Erythropoietin as an Innovative Add-on Therapy for Depression.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Biological Psychiatry

• Publication date

  2015-08-15

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1016/j.biopsych.2015.06.003PMID 26195176
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Erythropoietin Pathway: A Potential Target for the Treatment of Depression

  2016cited by this paper
• Hippocampal neuroplasticity in major depressive disorder.

  2015cited by this paper
• The economic burden of adults with major depressive disorder in the United States (2005 and 2010).

  2015cited by this paper
• Effects of Erythropoietin on Hippocampal Volume and Memory in Mood Disorders

  2015influential reference
• Cognitive dysfunction in unipolar depression: implications for treatment.

  2014cited by this paper
• Neuroplasticity and the next wave of antidepressant strategies

  2013cited by this paper
• World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders, Part 1: Update 2013 on the acute and continuation treatment of unipolar depressive disorders

  2013cited by this paper
• Magnetic resonance imaging studies in unipolar depression: systematic review and meta-regression analyses.

  2012cited by this paper
• Structural neuroimaging studies in major depressive disorder. Meta-analysis and comparison with bipolar disorder.

  2011cited by this paper
• Therapeutic potential of erythropoietin and its structural or functional variants in the nervous system

  2011cited by this paper
• Lifetime prevalence and age-of-onset distributions of mental disorders in the World Health Organization's World Mental Health Survey Initiative.

  2007cited by this paper

• Affective immunology: where emotions and the immune response converge

  2017cites this paper
• Erythropoietin Pathway: A Potential Target for the Treatment of Depression

  2016cites this paper